Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-06-07
2000-08-08
Eisenschenk, Chris
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 691, 4241891, 530395, 536 2372, A61K 3929, C12P 170
Patent
active
061000655
ABSTRACT:
HBV surface antigen particles, prepared by recombinant DNA technology are described, said particles being composed of epitopes from the group of surface peptides and/or core peptide of non-A, non-B hepatitis virus, hepatitis virus A and/or hepatitis virus B. Respective particles are especially characterized by a composition of different epitopes selected from pre-S and S peptides. There are also described DNA-sequences, plasmids and cell lines coding for respective HBV surface antigen particles as well as a new vaccine containing the same.
REFERENCES:
patent: 3636191 (1972-01-01), Blumberg et al.
patent: 4415491 (1983-11-01), Vyas
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4563423 (1986-01-01), Murray et al.
patent: 4599230 (1986-07-01), Milich et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4639371 (1987-01-01), Prince et al.
patent: 4649192 (1987-03-01), Van Wijnendaele et al.
patent: 4683136 (1987-07-01), Milich et al.
patent: 4696898 (1987-09-01), Fitts et al.
patent: 4710463 (1987-12-01), Murray
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4741901 (1988-05-01), Levinson et al.
patent: 4742158 (1988-05-01), Lehman et al.
patent: 4758507 (1988-07-01), Murray et al.
patent: 4777240 (1988-10-01), Moriarty et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4847080 (1989-07-01), Neurath et al.
patent: 4861588 (1989-08-01), Neurath et al.
patent: 4882145 (1989-11-01), Thornton et al.
patent: 4883865 (1989-11-01), Kubek
patent: 4895800 (1990-01-01), Tschopp et al.
patent: 4935235 (1990-06-01), Rutter et al.
patent: 4942125 (1990-07-01), Moriarty
patent: 4945046 (1990-07-01), Horii et al.
patent: 4959323 (1990-09-01), Acs et al.
patent: 4963483 (1990-10-01), Ellis et al.
patent: 4977092 (1990-12-01), Bitter
patent: 5011915 (1991-04-01), Yamazaki
patent: 5024938 (1991-06-01), Nozaki et al.
patent: 5039522 (1991-08-01), Neurath
patent: 5068185 (1991-11-01), Hopper et al.
patent: 5098704 (1992-03-01), Valenzuela
patent: 5102989 (1992-04-01), Sitrin et al.
patent: 5133961 (1992-07-01), Ellis et al.
patent: 5143726 (1992-09-01), Thornton et al.
patent: 5158769 (1992-10-01), Neurath et al.
patent: 5196194 (1993-03-01), Rutter et al.
patent: 5198348 (1993-03-01), Bitter
patent: 5204096 (1993-04-01), Neurath et al.
patent: 5242812 (1993-09-01), Even-Chen
patent: 5314808 (1994-05-01), Tiollais et al.
patent: 5324513 (1994-06-01), Sobczak et al.
patent: 5436139 (1995-07-01), Rutter et al.
patent: 5462863 (1995-10-01), Hsieh et al.
patent: 5565548 (1996-10-01), Neurath et al.
patent: 5591638 (1997-01-01), Tiollais et al.
patent: 5620844 (1997-04-01), Neurath et al.
patent: 5792463 (1998-08-01), Valenzuela et al.
patent: 5837249 (1998-11-01), Heber-Katz et al.
P. Winckur et al., "The Hepatitis A Virus Polyprotein Expressed by a Recombinant Vaccinia Virus Undergoes Protcolytic Processing and Assembly into Virus-like Particles", Journal of Virulogy, vol. 65, pp. 5029-5036. (1991).
A.R. Neurath et al., "Hepatitis B Virus Surface Antigen (HBsAg) as Carrier for Synthetic Peptides Having an Attached Hydrophobic Tail", Molecular Immunology, vol. 26, pp. 53-62. (1989).
B.E. Clarke et al., "Improved Immunogenicity of a Peptide Epitope After Fusion to Hepatitis B Core Protein", Nature, vol. 330, pp. 381-384. (1987).
D.R. Milich et al., "A Single 10-Residue Pre-S(1) Peptide Can Prim T Cell Help for Antibody Production to Multiple Epitopes Within the Pre-S(1), Pre-S(2), and S Regions of HBsAg.sup.1 ", The Journal of Immunology, vol. 138, pp. 4457-4465. (1987).
P. Valenzuela et al., "Synthesis and Assembly in Yeast of Hepatitis B Surface Antigen Particles Containing the Polyalbumin Receptor", Bio/Technology, vol. 3, pp. 317-320. (1985).
K. Cheng et al., "Hepatitis B Virus Large Surface Protein is Not Secreted but is Immunogenic When Selectively Expressed by Recombinant Vaccinia Virus", Journal of Virology, vol. 60, pp. 337-344. (1986).
D. Standring et al., "Assembly of Viral Particles in Xenopus Oocytes: Pre-Surface-Antigens Regulate Secretion of the Hepatitis B Viral Surface Envelope Particle", Proc. Natl. Acad. Sci. USA, vol. 83, pp. 9338-9842. (1986).
A. Neurath et al., "Location and Chemical Synthesis of a Pre-S Gene Coded Immunodominant Epitope of Hepatitis B Virus", Science, vol. 224, pp. 392-395. (1984).
D. Persing et al., "A Frameshift Mutation in the pre-S Region of the Human Hepatitis B Virus Genome Allows Production of Surface Antigen Particles but Eliminates Binding to Polymerized Albumin", Proc. Natl. Acad. Sci. USA, vol. 82, pp. 3440-3444. (1985).
M. Michel et al., "Synthesis in Animal Cells of Hepatitis B Surface Antigen Particles Carrying a Receptor for Polymerized Human Serum Albumin", Proc. Natl. Acad. Sci. USA, vol. 81, pp. 7708-7712. (1984).
A. Neurath et al., "Hepatitis B Virus Contains pre-S Gene-Encoded Domains", Nature, vol. 315, pp. 154-156. (1985).
V. Bruss and R. Thomssen, "Mapping a Region of the Large Envelope Protein Required for Hepatitis B Virion Maturation," Journal of Virology, vol. 68, No. 3, pp. 1643-1650 (1994).
Carloni et al., "A Transformed Vero Cell Line Stably Producing the Hepatitis B Virus Surface Antigen," Gene, vol. 31, pp. 49-57 (1984).
Delpeyroux, "A Poliovirus Neutralization Epitope Expressed on Hybrid Hepatitis B Surface Antigen Particles," Science, vol. 233, pp. 472-475 (1986).
Fritsch et al., "Virologie," C.R. Academy of Sciences, pp. 1453-1456 (1978) (English abstract).
F. Galibert et al., "Nucleotide Sequence of the Hepatitis B Virus Genome (Subtype ayw) Cloned in E. coli," Nature, vol. 281, pp. 646-650 (1979).
W. H. Gerlich and V. Bruss, "Functions of Hepatitis B Virus Proteins and Molecular Targets for Protective Immunity," in Hepatitis B Vaccines in Clinical Practice, R. W. Ellis, ed., Marcel Dekker, Inc., pp. 41-82 (1993).
Hsiung et al., "Efficient Production of Hepatitis B Surface Antigen Using a Bovine Papilloma Virus-Metallothionein Vector," Journal of Molecular and Applied Genetics, vol. 2, pp. 497-506 (1984).
E. Jacobs et al., "Hepatitis B Recombinant Vaccines," Biotech International, pp. 349-354 (Jul. 1991).
W. N. Katkov et al., "Immunogenicity of a `pre-S2 plus S` Hepatitis B Vaccine in Healthy Adults," Journal of Viral Hepatitis, vol. 1, pp. 79-83 (1994).
LeClerc et al., "A Synthetic Vaccine Constructed by Copolymerization of B and T Cell Determinants," European Journal of Immunology, vol. 17, pp. 269-273 (1987).
O. Marquardt et al., "Cell-Type Dependent Expression and Secretion of Hepatitis B Virus pre-S1 Surface Antigen," Postgraduate Medical Journal, vol. 63, Supp. 2, pp. 41-50 (1987).
W. J. McAleer et al., "Human Hepatitis B Vaccine from Recombinant Yeast," Nature, vol. 307, pp. 178-180 (1984).
Milich et al., "Immune Response to Hepatitis B Virus Core Antigen (HBcAg): Localization of T Cell Recognition Sites within HBcAg/HBeAg," Journal of Immunology, vol. 139, pp. 1223-1231 (1987).
Milich et al., "Nonoverlapping T and B Cell Determinants on an Hepatitis B Surface Antigen Pre-S(2) Region Synthetic Peptide," J. of Exp. Med., vol. 164, pp. 532-547 (1986).
Milich et al., "T Cell and B Cell Recognition of Native and Synthetic Pre-S Region Determinants on Hepatitis B Surface Agent," Vaccines, vol. 86, pp. 377-382 (1986).
Milich et al., "Two Distinct But Overlapping Anitbody Binding Sites in the Pre-S(2) Region of HBsAg Localized Within 11 Continuous Residues," Journal of Immunology, vol. 137, pp. 2703-2710 (1986).
Milich et al., Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface Antigen, Science, vol. 228, 1195-1199 (1985).
E. Miskovsky et al., "Comparative Safety and Immunogenicity of Yeast Recombinant Hepatitis B Vaccines Containing S and pre-S2+S Antigens," Vaccine, vol. 9, pp. 346-350 (1991).
Okamoto et al., "Nucleotide Sequence of a Cloned Hepatitis B Virus Genome, Subtype ayr: Comparison with Genomes of the Other Three Subtypes," Journal of General Virology, vol. 67, pp. 2305-2314 (1986).
Y. Ono et al., "The Complete Nucleotide Sequences of the Cloned Hepatitis B Virus DNA; Subtype adr and adw," Nucleic Acids Research, vol. 11, pp. 174
Eisenschenk Chris
Medeva Holdings B.V.
Zeman M. K.
LandOfFree
Hepatitis B surface antigen vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis B surface antigen vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis B surface antigen vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1149077